David Kram

Associate Professor

University of North Carolina

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Kram is an Associate Professor at the University of North Carolina, USA. His research focuses on pediatric brain tumors, including therapeutic approaches, patient-derived models, and the integration of proteogenomics in understanding tumor biology. Additionally, he is involved in exploring interventions related to influenza vaccination and the impact of COVID-19 on pediatric oncology care.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Daniel A. Morgenstern

CANADA

View details

Uri Tabori

UNITED STATES

View details

Pei Wang

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Michael Capra

Consultant Paediatric Oncologist, Clinical Professor - Trinity College Dublin

IRELAND

View details

Kathreena M Kurian

University of Bristol

UNITED KINGDOM

View details

Jessica Boult

Institute of Cancer Research

UNITED KINGDOM

View details

Madhumita Dandapani

Clinical Associate Professor of Paediatric Oncology

University of Nottingham

UNITED KINGDOM

View details

Monika Davare

Oregon Health & Science University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Kram

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Therapeutic approaches for targeting the pediatric brain tumor microenvironment

Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine

Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates.

COVID-19-Related Reduction in Emergency Health Care Utilization Among Febrile Pediatric Oncology Patients.

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.

Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.

Tumor Lysis Syndrome.

Collaborators (8)

Daniel A. Morgenstern

Uri Tabori

Pei Wang

Michael Capra

Kathreena M Kurian

Jessica Boult

Madhumita Dandapani

Monika Davare

Make your next move.